MSF challenges Gilead’s patent application for hepatitis C combination treatment in China
Gilead recently launched one of these drugs for $100/pill in China
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
International seminar on cleanrooms
Contamination Control Society of India (CCSI) will organise a seminar on cleanrooms. Three well know international experts and 2…
Indian firm bags nod to conduct Phase-I clinical trial on Zika vaccine: Govt
The Indian firm had submitted an application to the drugs controller recently
Natco launches Hepatitis B drug
The company is one of the first entities to launch the generic version of the drug under its brand Tafnat
Ion Exchange (India) launches INDION SWIFT 5Gx
The high purity water generation product will cater to the special needs of the pharma industry
Sanofi India appoints N Rajaram as Managing Director
Rajaram will succeed Shailesh Ayyangar, who served as MD for 12 years
Entrepreneur Dr Srinubabu buys Canada’s Health Informatics Company PULSUS
To open new centres in Chennai and Gurgaon
AIDAN welcomes SC order on FDCs
AIDAN filed a Special Leave Petition in the Supreme Court, alongside the government’s own petition, challenging an order of the…
Torrent Pharma raises Rs 1,000 crs via NCDs
The company has issued non-convertible debentures for an amount of Rs 1,000 crore on December 14, 2017
Natco Pharma raises Rs 915 cr via QIP
The company's committee of directors decided to allocate 1 crore shares